Browsing: Pharma

Sandoz didn’t mince words about the huge but largely untapped opportunity facing biosimilar makers, as…

AbbVie CEO Robert Michael will be paid $32.5 million in 2025, his second year on…

In BioNTech’s search for a new CEO, the German company is looking for a new…

Amid the company’s efforts to resolve issues raised during an FDA inspection early last year,…

After hinting at expanding plasma-based manufacturing in the U.S. late last year, CSL is moving…

Nearly five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy…

Emma Walmsley leaves on a high note after nearly nine years as GSK’s CEO, with…

The FDA is doubling down on its goal of increasing the availability of biosimilar drugs…

Eli Lilly defended its CEO David Rix’s $36.7 million compensation shortly before filing a proxy…

Hims & Hers and Novo Nordisk have officially put down swords. After years of public…